The present study investigated the poststress (PS) cellular and molecular changes in the hippocampus of rats subjected to repeated restraint stress (RS) and the effects of chronic administration of an antidepressant drug, venlafaxine, on these changes. It was found that RS suppressed hippocampal cell proliferation, decreased brain-derived neurotrophic factor (BDNF) levels, and increased both the levels of copper/zinc superoxide dismutase (Cu/Zn-SOD) and the number of Cu/Zn-SOD immunostained hippocampal interneurons. In venlafaxine-treated rats, the changes in cell proliferation, BDNF levels, and the number of Cu/Zn-SOD interneurons returned to control levels on PS Days 21, 14, 7, respectively. In vehicle-injected rats, BDNF and the number of Cu/Zn-SOD interneurons returned to control levels on PS Days 21 and 14, respectively, but cell proliferation was still suppressed on PS Day 21. The stress-induced elevation of Cu/Zn-SOD protein remained during the 3-week PS period, and it was further increased by about 20% after 3 weeks of venlafaxine administration.
INTRODUCTION
Postmortem and brain imaging studies have revealed atrophy or loss of neurons in the prefrontal cortex and hippocampus of both depressed and anxious patients. [1] [2] [3] In animals, hippocampal damage has been reported following stressful conditions in which the levels of glucocorticoids are elevated. For example, marked hippocampal degeneration was found in subordinate vervet monkeys who had died after experiencing prolonged social stress within their breeding group. 4 In rats, chronic restraint stress (RS) induces atrophy of the apical dendrites of CA3 pyramidal neurons, 5, 6 and alters the ultrastructure of the hippocampal mossy fiber terminals that synapse on the CA3 pyramidal cell dendrites. 7 Chronic psychosocial stress, such as exposing subordinate adult male tree shrews to the sight of a dominant male tree shrew, 8 or exposing adult rats to the odor of a fox, 9 inhibits the generation of new granule neurons in the hippocampal dentate gyrus.
Hippocampal plasticity is not only altered in patients with chronic major depressive disorder and in stressed animals, but is also affected by antidepressant treatments. In rats, chronic antidepressant administration increases BDNF mRNA levels in limbic structures, most notably in the hippocampus, 10, 11 and increases BDNF immunoreactivity in the hippocampal pyramidal and dentate granule cell layers. 12 Chronic antidepressant treatment also increases neurogenesis in the hippocampus. 13, 14 Moreover, chronic pretreatment with either electroshock or antidepressant drugs blocks the downregulation of BDNF mRNA in rats exposed to RS, 10 or to the stress of forced swimming. 15 Although the above studies indicate the involvement of hippocampal plasticity in the pathogenesis and treatment of depression, further studies are still required to demonstrate a neuroprotective role for antidepressants in treating patients with major depressive disorder. Specifically, more information about the effects of chronic antidepressant treatment on stress-induced alterations in the hippocampus is needed. Therefore, the present study used an animal model of repeated RS that induces alterations in the hippocampus, and determined the effects of the chronic administration of venlafaxine therein.
The antidepressant drug venlafaxine (1-[2-(dimethylamino)-1-(4-methyoxyphenyl)-ethyl] cyclohexanol) is a dual serotonin (5-hydroxytryptamine, 5-HT) and noradrenaline (NA) reuptake inhibitor. Although this action on NA and 5-HT systems is observed following acute administration, long-term treatment with the drug is required in order to achieve clinical efficacy in patients with major depressive disorder. This suggests that the chronic effects of the drug are more complex, and that molecular and cellular events downstream from the neurotransmitter reuptake blockade may be more relevant to the therapeutic effects of venlafaxine on depressive symptoms. The objectives of the present study were: (1) to demonstrate the repeated RSinduced changes in rat hippocampus as measured at cellular and molecular levels; (2) to see if the repeated RS-induced changes are reversible over time; and (3) to determine the effects of chronic administration of venlafaxine on the progress of recovery of the repeated RS-induced changes in the hippocampus. Emphasis was put on the measurement of hippocampal cell proliferation, and hippocampal levels of BDNF and Cu/Zn-SOD. Although the first two parameters have been observed individually in previous studies, the parallel observation of the both markers in the same study is of interest as BDNF appears to be required for adult neurogenesis. 16, 17 Since oxidative stress and the modulation of antioxidant enzymes may contribute to the effects of chronic stress in the central nervous system (CNS), 18 we observed the time-course of Cu/Zn-SOD expression following repeated RS. We have previously demonstrated that the expression of this antioxidant enzyme was also regulated by antidepressants in a nonstress condition.
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RESULTS
Neuropathology
Nissl staining did not reveal any differences among the experimental groups in the hippocampal pyramidal cell layer or dentate granule cell layer of the sections examined (not shown). No apoptosis was observed in any of the transferase dUTP nick-end labeling (TUNEL) tested sections from the experimental rats (not shown).
Poststress Changes in Cell Proliferation in the Dentate Gyrus and Its Regulation by Venlafaxine
Image a in Figure 1 shows the typical pattern of proliferating cells found in the dentate gyri of rats from the normal, no stress, control group (group N). Proliferating cells were found predominantly in the subgranular zone (SGZ) along the subpyramidal and infrapyramidal blades of the dentate gyrus, and occasionally in the hilus. The 5-bromo-2 0 -deoxyuridine (BrdU) labeled cells occurred singly or in small clusters. Image b is from a rat subjected to a paradigm of repeated RS (group Str). Comparing Figure 1a and b, it is clear that there are many more BrdU-labeled cells in the dentate gyrus of the normal, nonstressed rat. The quantification of the BrdU-labeled cells in the groups N, Str, Str þ Sal-3 (intraperitoneal (i.p.) injection of saline once a day for 3 weeks after the last RS session), and Str þ Ven-3 (i.p. injecton of 5 mg/kg venlafaxine once a day for 3 weeks after the last RS session) is illustrated in Figure 1c . Three days of repeated RS significantly reduced the number of BrdUlabeled cells to 69% of the N group level (Po0.01). After 3 weeks, cell proliferation was still reduced in the Str þ Sal-3 group (83% of N group level; Po0.05), although the difference between Str þ Sal-3 and Str is also significant (Po0.05). In Str þ Ven-3 group, the number of BrdU-labeled cells had returned to the N group level and significantly exceeded Str þ Sal-3 group level (Po0.05).
Poststress Changes in BDNF Levels in Hippocampal Neurons and Its Regulation by Venlafaxine
The upper panel of Figure 2 is a representative Western blot showing the immunochemically reactive products of BDNF from all experimental groups. Compared to the Lane N (from a normal control rat), the Lane Str (from a rat in the stress only group) has a smaller surface area but comparable optic density. The Lane Str þ Sal-1 (from a rat who had received i.p. injection of saline once a day for 1 week after the last RS session) has the smallest surface area. The bottom panel of Figure 2 shows the quantitative data of Western blot analyses, taking the level of BDNF of the N group as 100%. The BDNF level of the Str group is about 85% of the N group level (Po0.05). On PS Day 7, the BDNF level was 68% of the N group level in the Str þ Sal-1 group (Po0.01), and 81% in the Str þ Ven-1 group (Po0.05). On PS Day 14, the BDNF level was still reduced in the Str þ Sal-2 group (79% of the N group level, Po0.05; the rats in this group received i.p. injection of saline once a day for 2 weeks after the last RS session), but had returned to control level in the Str þ Ven-2 group (the rats in this group received i.p. injection of 5 mg/ kg venlafaxine once a day for 2 weeks after the last RS session). By PS Day 21, the BDNF level of the Str þ Sal-3 group had returned to the control level and there was no significant difference between the groups Str þ Sal-3 and Str þ Ven-3. The BDNF level of the Str þ Sal-3 group is significantly higher than the level of Str þ Sal-1 group (Po0.01). Figure 3 is composed of the immunohistochemical images showing the pattern of BDNF-like immunoreactivity (BDNF-LI) in the hippocampus of rats from each of the experimental groups. The typical pattern of BDNF-LI in the hippocampus is shown in Photograph a (from a rat in N group). The greatest intensity of BDNF immunostaining was seen in the hippocampal pyramidal cell layer and in the dentate granule cell layer, while the neuropil of the hippocampus was immunostained weakly. The optical density of BDNF-LI in the hippocampal pyramidal cell layer and the dentate granule cell layer in Photograph b (from a rat in Str group) is slightly lower as compared with that in a. In Photograph c (from a rat in Str þ Sal-1 group), the BDNF-LI in the hippocampal pyramidal cell layer and the dentate granule cell layer reached the lowest level while the immunostaining in hippocampal neuropil became moderate. This moderate immunostaining in hippocampal neuropil remained thereafter although the BDNF-LI in the hippocampal pyramidal cell layer and the dentate granule cell layer gradually returned to the N group level (see Photograph g from a Str þ Sal-3 rat) and even became somewhat higher in Photograph h (from a Str þ Ven-3 rat).
Poststress Changes in the Number of Cu/Zn-SOD Immunostained Interneurons and Cu/Zn-SOD Protein Levels in the Hippocampus and Their Regulation by Venlafaxine The upper panel of Figure 4 is a representative Western blot showing the immunochemically reactive bands of Cu/Zn-SOD from all experimental groups. Lane N has the smallest surface area and all other lanes have comparable surface areas. The lanes from venlafaxine-injected rats (Str þ Ven-1, Str þ Ven-2, and Str þ Ven-3) are somewhat denser than the lanes from saline-injected rats (Str þ Sal-1, Str þ Sal-2, and Str þ Sal-3). The bottom panel of Figure 4 shows the quantitative data of Western blot analyses, taking the level of Cu/Zn-SOD of the N group as 100%. The level of Cu/Zn-SOD in the Str group is significantly higher by about 40% than that of the N group (Po0.01). This RS-induced increase in Cu/Zn-SOD remained during the 3-week poststress period in all groups. In fact, 3 weeks of venlafaxine injections caused a significant further increase of Cu/Zn-SOD by about 20% as compared to the Str þ Sal-3 group (Po0.05). Immunohistochemical staining showed that the hippocampal pyramidal cell layer and the dentate granule cell layer in stressed rats were more intensely stained as compared to the staining in sections from normal, nonstressed rats (not shown). In Figure 5 , the photographs show Cu/Zn-SOD immunostained interneurons in the hippocampal CA3 and Figure 1 Acceleration of restoration of the cell proliferation in the dentate gyrus by venlafaxine following repeated RS. Cell proliferation in the hippocampal dentate gyrus of the rat was demonstrated with BrdU immunohistochemistry as described in Materials and Methods. The upper panels show proliferating cells in the dentate gyri of a normal nonstressed rat (a) and of a stressed rat (b). In nonstressed rats, most of proliferating cells are found in the subgranular zone (SGZ), defined as a two-to-three-cell-body-wide zone between the granule cell layer (GCL) and the hilus (a). After repeated RS, the number of BrdU-labeled cells was greatly reduced, as seen in Photograph b. The histograms of this figure show the number of BrdU-labeled cells in the hippocampal dentate gyrus of nonstressed rats (N) receiving 4 h restraint stress for 3 days (Str), rats daily receiving i.p. injections of saline (Str þ Sal-3) or 5 mg/kg of venlafaxine (Str þ Ven-3) for 3 weeks after 3 days of restraint stress. Repeated RS resulted in a significant decrease in the number of BrdU-labeled cells (Str) as compared to normal, nonstressed controls (N). This decrease was still seen in the Str þ Sal-3 group. The number of BrdU-labeled cells in the Str þ Ven-3 group had returned to the N group level, and is significantly higher than that of the Str þ Sal-3 group. The data are expressed as mean7SD (n ¼ 4). *Po0.05, **Po0.01 vs N group; # Po0.05, Str þ Ven-3 vs Str þ Sal-3. the dentate hilus. These interneurons, scattered in all layers of the hippocampus, and predominantly polymorphic, were counted using Image-Pro Plus. The numbers of Cu/Zn-SOD immunostained interneurons were normalized, taking the number in the N group to be 100% (see the histograms). Three days of repeated RS significantly increased the number of Cu/Zn-SOD immunostained interneurons in CA3 and hilus by 40% (Po0.05) and 75% (Po0.01), respectively. These increases had returned to the N group levels after 7 days of venlafaxine injections. However, in saline-injected rats, it took 2 weeks (CA3) or 3 weeks (hilus) for the number of Cu/Zn-SOD immunostained interneurons to return to the N group levels.
DISCUSSION
In the present study, we found that the levels of BDNF and the degree of cell proliferation in the hippocampus of adult rats are decreased by repeated RS, in concordance with previous reports. 9, [20] [21] [22] [23] [24] [25] The fact that different stress paradigms have the same effect on cell proliferation in the dentate gyrus suggests a common mechanism underlying the suppression of cell proliferation in this region by various stressful experiences. It is likely that elevated circulating levels of adrenal steroids induced by the various stress conditions are responsible for the inhibition of cell proliferation in the dentate gyrus. In line with this notion, previous studies have found that experimental increases in . The greatest intensity of BDNF immunostaining is seen in the hippocampal pyramidal cell layer and in the dentate granule cell layer. The neuropil of the hippocampus is weakly immunostained. The optical density of BDNF-LI in the hippocampal pyramidal cell layer and the dentate granule cell layer in (b) (Str group rat) is slightly lower as compared with that in (a). In photograph c (Str þ Sal-1 group rat), the BDNF-LI in the hippocampal pyramidal cell layer and the dentate granule cell layer reached the lowest level while the immunostaining in hippocampal neuropil became moderate. This moderate immunostaining in hippocampal neuropil remained thereafter although the BDNF-LI in the hippocampal pyramidal cell layer and the dentate granule cell layer gradually returned to the N group level (see photograph g from Str þ Sal-3) and even became a little bit higher in photograph h (Str þ Ven-3 rat). the levels of adrenal steroids result in significant decreases in the rate of granule cell production, 26, 27 and that removal of adrenal steroids stimulates the proliferation of granule cell precursors. 28 Although the levels of adrenal steroids were not measured in the present study, previous reports have shown that RS increases blood levels of glucocorticoids in rats. 6 In addition, the decrease in the level of BDNF in the dentate gyrus may partially contribute to the suppression of cell proliferation induced by repeated RS since the administration of exogenous BDNF triggers a burst of cell proliferation and the appearance of new neurons in the parenchyma of the forebrain, 29 and induces neuronal recruitment from endogenous progenitor cells in both neostriatal and olfactory areas. 30 Repeated RS markedly increased both the levels of Cu/Zn-SOD protein and Cu/Zn-SOD-LI in hippocampal principal neurons (including hippocampal pyramidal neurons and dentate granular neurons). The presence of elevated Cu/Zn-SOD protein likely offers a greater protection against neuronal damage mediated by reactive oxygen species. 31, 32 In support of this notion, the immunostaining of Cu/Zn-SOD in hippocampal pyramidal cell layer is much weaker than that in granule cell layer, and the latter is more resistant than the former to oxidative stress. 10, 18 Therefore, the higher levels of Cu/Zn-SOD protein and Cu/Zn-SOD-LI in hippocampal principal neurons of stressed rats are indicative of the neurons' response to repeated RS, and thereby protect these neurons against the stress insult. Similarly, the increase in the number of Cu/Zn-SOD immunostained hippocampal interneurons seen in stressed rats may reflect the activation of the interneurons by repeated RS. This explanation is in accordance with the previous findings that stressful, noxious, or anxiogenic stimuli markedly increase the firing activity of NA neurons, which in turn increases the extracellular concentration of NA in the hippocampus and increases the spontaneous firing rate of hippocampal interneurons. [33] [34] [35] [36] [37] [38] [39] The hippocampal interneurons are all GABAergic and inhibitory. Each of these interneurons innervates thousands of hippocampal principal neurons. Therefore, the regulation of a small number of hippocampal interneurons may lead to a global modulation of hippocampal activity. 40 In this context, the activation of hippocampal interneurons may contribute to the stress-induced decrease in the levels of BDNF in principal neurons.
It is of interest that hippocampal levels of BDNF in the Str þ Sal-3 rats had returned to normal while the number of BrdU-labeled cells in the dentate gyrus had not. In other words, the restoration of neurogenesis is slower than that of BDNF protein. This result supports the current understanding that BDNF is not a main factor regulating neurogenesis in the dentate gyrus. 47 Besides BDNF, other factors are adrenal steroids, as discussed above, pCREB (phospho-CREB), and 5-HT. It has been reported that chronic antidepressant treatment increases the levels of pCREB, [41] [42] [43] and that rolipram, a chemical inhibitor of cAMP-specific phosphodiesterase type IV, increases adult neurogenesis 44 as well as levels of pCREB in the hippocampus. 41 Recent research suggests that neurogenesis is decreased by serotonergic lesions, 45 and increased by stimulation of 5-HT 1A receptors. 46 Further work needs to be done to find out why the levels of BDNF continue to fall for 7 days after the stress. This further decrease in BDNF suggests that other molecular events may precede or accompany the decrease in the levels of BDNF in hippocampal principal neurons. For example, the molecular events occurring in hippocampal interneurons, as discussed above and later, may play important roles in linking the changes in the noradrenergic/serotonergic systems and the changes in the expression of BDNF in hippocampal principal neurons under conditions of stress and chronic exposure to antidepressant drugs ( Figure 6 ).
We observed that during the 3-week poststress period, the levels of Cu/Zn-SOD protein and Cu/Zn-SOD-LI in hippocampal principal neurons remained elevated. The high levels of Cu/Zn-SOD may be necessary for the hippocampal neurons to recover from the effects of the repeated RS as discussed above. In fact, the present study showed that venlafaxine administration for 3 weeks further increased the levels of Cu/Zn-SOD protein and Cu/Zn-SOD-LI. In contrast to hippocampal principal neurons, the stress-induced elevated number of Cu/Zn-SOD immunostained interneurons returned to the N group value after venlafaxine administration for 7 days (see Figure 5) . This difference may be explained on the basis of anatomical and physiolo- 40,47 Endogenous 5-HT, for example, inhibits hippocampal GABAergic interneurons, thereby removing their inhibitory effect on hippocampal principal neurons, 40, 48, 49 although it directly inhibits the firing rate of pyramidal neurons via activating 5-HT1A receptors localized on dendrites of the cells. 50 According to this knowledge, we suggest that chronic administration of venlafaxine increases the level of extracellular 5-HT in the hippocampus, which in turn exerts an inhibitory effect on hippocampal interneurons, thereby removing the interneuron-mediated inhibition of the principal neurons. In consequence, the activity of hippocampal principal neurons is increased, thus facilitating the recovery of BDNF level in hippocampal principal neurons to prestress levels as seen in the venlafaxine-treated groups ( Figure 6 ). Both the increased 5-HT and increased BDNF produced by the drug may contribute to the accelerated recovery of neurogenesis in the dentate gyrus.
14,46,the present study Although venlafaxine is a dual 5-HT and NA uptake inhibitor, we believe that the dose (5 mg/kg) used in the present study did not change the synaptic level of NA, since a dose of 20 mg/kg has been reported to be necessary to block NA reuptake. 51 In summary (Figure 6 ), repeated RS suppressed hippocampal cell proliferation, decreased BDNF levels, and increased the levels of Cu/Zn-SOD in hippocampal principal cells. The suppression of hippocampal cell proliferation by the repeated RS is likely due to the stress-induced increase in the levels of circulating glucocorticoids, 52, 53 and to the decrease in BDNF levels (the present study). Repeated RS also activated hippocampal interneurons, as indicated by the marked increase in the number of Cu/Zn-SOD immunostained interneurons. This effect may be attributed to the increase in the extracellular concentration of NA in the hippocampus under stressful conditions. [33] [34] [35] [36] [37] [38] [39] The high level of extracellular NA in the hippocampus in turn inhibits the hippocampal principal neurons, thereby reducing the expression of BDNF in these neurons (the present study). The stress-induced increase in the number of Cu/Zn-SOD interneurons returned to control level by venlafaxine on PS Day 7. This effect indicates the inhibition of the interneurons by the drug that increases extracellular 5-HT in the hippocampus. The high level of 5-HT not only inhibits local inhibitory interneurons, 49 ,the present study but also increases BDNF, 54, 55 ,the present study and cell proliferation in the dentate gyrus.
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MATERIALS AND METHODS
All of the procedures involving animals were in strict accordance with the guidelines established by the Canadian Council on Animal Care, and approved by the University of Saskatchewan Animal Care Committee.
Animals and Treatment Paradigms
Adult male Sprague-Dawley rats weighing 200-225 g were purchased from Charles River Laboratories (St Constant, PQ, Canada). The rats were housed, two rats to a cage, on a 12-h light/dark cycle, with free access to food and water. After 1 week of acclimatization, the rats were randomly divided into eight groups of 10 rats each (Table 1) . Except for the rats in the group N, which were brought into the experimental room and only handled, the rats in the other seven groups were subjected to RS by placing individual rats into a Plexiglas tube 20 for 4 h a day on 3 consecutive days. At 1 h after the third period of restraint, four rats in the group Str and four rats in the group N were given, at 2-h intervals, three i.p. injections of 50 mg/kg of BrdU (Sigma, St Louis, MO, USA). At 24 h after the last injection of BrdU, the four BrdU-treated rats in each of these two groups were deeply anesthetized by an i.p. injection of chloral hydrate, then transcardially perfused with 0.1 M PBS for 5-6 min, followed by 4% paraformaldehyde in PBS for 15-20 min. The brains were removed, postfixed overnight in 4% paraformaldehyde in PBS at 41C, and placed in 20% sucrose in PBS for 3 days. Then the brain samples were frozen on dry ice and stored at À701C until used for histological examinations, and for immunocytochemical detections of BrdUlabeled cells and of BDNF-and Cu/Zn-SOD-containing cells in the hippocampus. The other six non-BrdU-treated rats in each of the N and Str groups were decapitated following deep anesthesia with chloral hydrate. Their brains were removed and the hippocampi were dissected out. The dissected hippocampi were frozen on dry ice and stored at À701C until used for Western blot analysis to detect the levels of BDNF and Cu/Zn-SOD proteins in the hippocampus.
Table 1 Experimental design
Groups (10 rats/group) (4 rats/group) (6 rats/group)
Nissl TUNEL
At 24 h after the last stress session, the rats in each of the other six groups received a daily i.p. injection of freshly prepared venlafaxine HCl (Wyeth-Ayerst Research, NJ, USA), or an equal volume of the saline vehicle, for 1, 2, or 3 weeks ( Table 1 ). The dosage of venlafaxine used in this study, i.e. 5 mg/kg, has been shown to upregulate the expression of BDNF in hippocampal neurons of normal rats in a previous study.
12 After 1 week of daily injections, the rats in the groups Str þ Sal-1 and Str þ Ven-1 were deeply anesthetized with chloral hydrate 24 h after their last injection. Four rats in each of these two groups were prepared for BDNF and Cu/ Zn-SOD immunocytochemical staining, and the remaining six rats were prepared for Western blot analysis. Similarly, after 2 weeks of daily injections, the rats in the groups Str þ Sal-2 and Str þ Ven-2 were prepared for immunocytochemical staining or Western blot analysis. After 3 weeks of injections, four rats in each of the groups Str þ Sal-3 and Str þ Ven-3 were injected with BrdU solution and prepared as described above for the BrdU-treated rats in the N and Str groups. These rats were used for immunocytochemical detection of BrdU-labeled cells, and of BDNF-and Cu/Zn-SOD-containing cells in the hippocampus. The remaining rats in these two groups were used for Western blot analysis.
Western Blot Analysis
The levels of BDNF and Cu/Zn-SOD proteins in the dissected hippocampi were measured by Western blot analysis. Each frozen hippocampus was homogenized and lysed in 2 ml of PBS containing 1% Nonidet P-40 and the following protease inhibitors: phenylmethylsulfonyl fluoride (100 mg/ml), leupeptin (1 mg/ml), pepstatin (1 mg/ml), and aprotinin (1 mg/ ml). All of these protease inhibitors were purchased from Sigma (St Louis, MO, USA). Lysates were cleared by centrifugation, and the total protein concentration in each sample was determined spectrophotometrically at A 595 nm using the BCA protein assay reagent kit (Pierce, Rockford, IL, USA). Samples containing 50 mg protein/10 ml were denatured in gel-loading buffer and separated on 12% SDS-PAGE gels. Following electrophoresis, the proteins were transferred to polyvinyldifluoride membranes (Biorad, Hercules, CA, USA). After preblocking in 5% skim milk powder in PBS, the membranes were incubated at 41C with the primary antibody to BDNF (1:1000 for 72 h) or the primary antibody to Cu/Zn-SOD (1:2000 for 48 h), and then incubated for 2 h at room temperature in horseradish peroxidase-linked secondary antibodies (Biorad, Hercules, CA, USA). Control for protein loading was performed by reprobing membranes with an antibody against b-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Immunoreactive bands were detected by a chemoluminescent Western blot kit (Amersham, Piscataway, NJ, USA), and then exposed to Kodak Biomax film (Eastman Kodak, Rochester, NY, USA). Images were collected with the ImageMaster VDS (Amersham Pharmacia Biotech, Piscataway, NJ, USA), and analyzed using Image-Pro Plus (Media Cybernetics, Silver Spring, MD, USA). The results were expressed as the product of the optical density and the surface area of a given band as described by Amateau et al. 56 
BrdU Incorporation Analysis
The paraformaldehyde-fixed brains were blocked, frozen to the stage of a freezing microtome, and 30 mm serial sections were cut through the entire hippocampus (Plates 18-28, Paxinos and Watson, 1982) . 57 Every sixth section was collected in PBS and processed for BrdU immunocytochemistry as follows. Sections were incubated in 2 N HCl for 30 min at 371C, then in 0.1 M borate buffer (pH ¼ 8.4) for 10 min at room temperature. After washing in PBS, sections were incubated for 30 min in 0.6% hydrogen peroxide to eliminate endogenous peroxidases. After blocking with 5% normal horse serum in PBS containing 1% Triton X-100, sections were incubated with anti-mouse BrdU (1:1000; Boehringer-Mannheim, Indianapolis, IN, USA) for 48 h at 41C. Sections were then incubated for 1 h with a secondary antibody (biotinylated horse anti-mouse; Vector Laboratories, Burlingame, CA, USA) followed by amplification with an avidin-biotin complex (Vector Laboratories), and visualized with diaminobenzidine (DAB). Immunocytochemical controls were performed with the same protocol but omitting the primary antibody. No BrdU-labeled cell was found in any controls. All BrdU-labeled cells in the granule cell layer, the hilus, and SGZ, regardless of size or shape, were counted using Image-Pro Plus software. To enable counting of cell clusters, cells were examined under Â 400 or Â 1000 magnification, omitting cells in the outermost focal plane. The same neuron could not be counted more than once because only every sixth section was examined. This unbiased stereology protocol has been used by other investigators in reporting quantitative BrdU labeling. [58] [59] [60] The number of BrdU-labeled cells per section was determined and multiplied by six to obtain the number of BrdUlabeled cells per dentate gyrus.
Immunocytochemistry
As described previously, 12, 61 sections were pretreated with 0.3% hydrogen peroxide in methanol for 30 min to block endogenous peroxidase, washed with PBS, and incubated for 1 h at room temperature with a blocking solution composed of 5% normal serum, 1% BSA and 1% Triton X-100 in PBS. Sections were then incubated with one of the primary antibodies, at dilutions of 1:1000 (polyclonal antibody to BDNF; RDI, Flanders, NJ, USA), or 1:4000 (polyclonal antibody to Zn/Cu-SOD; RDI, Flanders, NJ, USA) in PBS containing 0.5% Triton X-100 and 1% normal serum, for 48 h at 41C followed by 2 h at room temperature. The primary antibodies were localized using Vectastain Elite reagents (Vector Laboratories, Burlingame, CA, USA), and the reaction products were developed using 0.025% DAB as chromogen, diluted in Tris/HCl-buffered saline (TBS, 0.05 M, pH 7.6), and 0.03% hydrogen peroxide as substrate. Immunocytochemical controls were similarly treated but without the addition of the primary antibodies. No positive immunostaining was found in any controls.
Neuropathological Analysis
Nissl staining was done using standard histological methods. TUNEL was performed according to the protocol of the 
Data Analysis
Student's t-test was used to compare quantitative data from N and Str groups. Two-way ANOVA was used to analyze the poststress changes in the levels of BDNF and Cu/Zn-SOD proteins in hippocampus tissue, and the poststress changes in the number of BrdU-labeled cells and of Cu/Zn-SOD immunocytochemically labeled interneurons in the CA3 and the hilus of the dentate gyrus, with treatment and time after restraint stress as fixed factors. Newman-Keuls tests were used for post hoc comparisons.
